New study tracks how cancer surgery affects Kids' walking
NCT ID NCT07502885
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how well children walk after having surgery for bone or soft tissue cancer in their legs. Researchers will use 3D cameras, muscle sensors, and wearable devices to measure movement in 300 children, comparing them to healthy kids of the same age. The goal is to understand what causes walking problems and how they change over time, so doctors can find better ways to help.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better understand and predict walking problems in children after cancer surgery, leading to improved rehabilitation strategies.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly improve outcomes for participants, and results may take years to translate into clinical practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GAIT DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
St. Jude Children's Research Hospital
RECRUITINGMemphis, Tennessee, 38105, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Tumor-Injected drug combo outlast standard care in advanced sarcoma?
- Cancer-Killing virus injected directly into tumors shows promise in Mid-Stage trial
- New drug combo shows promise for rare sarcoma
- New chemo combo shows promise for rare sarcoma
- New drug cocktail shows promise for rare sarcomas
- Scientists launch international registry to crack the code of ultra-rare cancer EHE